Cencora, Inc.
General ticker "COR" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $54.0B (TTM average)
Cencora, Inc. follows the US Stock Market performance with the rate: 29.4%.
Estimated limits based on current volatility of 2.5%: low 337.12$, high 354.33$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (irregularly): last record date 2025-11-14, amount 0.60$ (Y0.18%)
- Total employees count: 13700 as of 2001
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [232.50$, 335.01$]
- 2026-09-30 to 2027-09-30 estimated range: [235.50$, 343.32$]
Financial Metrics affecting the COR estimates:
- Negative: with PPE of 18.7 at the end of fiscal year the price was very high
- Positive: -3.60 < Operating profit margin, % of 0.87
- Negative: Shareholder equity ratio, % of 2.28 <= 18.93
- Positive: Industry inventory ratio change (median), % of -0.24 <= -0.15
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.01
- Negative: 0.01 < Interest expense per share per price, % of 0.67
- Positive: -8.75 < Industry operating profit margin (median), % of 0.74
- Positive: Inventory ratio change, % of -0.08 <= 0
- Positive: 0 < Industry earnings per price (median), % of 1.10
Short-term COR quotes
Long-term COR plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $262,173.41MM | $293,958.60MM | $321,332.82MM |
| Operating Expenses | $259,726.90MM | $290,918.47MM | $318,521.24MM |
| Operating Income | $2,446.51MM | $3,040.13MM | $2,811.58MM |
| Non-Operating Income | $-285.68MM | $-1,036.16MM | $-553.25MM |
| Interest Expense | $275.65MM | $248.68MM | $388.23MM |
| Income(Loss) | $2,160.84MM | $2,003.97MM | $2,258.34MM |
| Taxes | $428.26MM | $484.70MM | $690.52MM |
| Profit(Loss)* | $1,745.29MM | $1,509.12MM | $1,554.17MM |
| Stockholders Equity | $522.00MM | $645.94MM | $1,747.09MM |
| Inventory | $17,454.77MM | $18,998.83MM | $20,492.48MM |
| Assets | $62,558.75MM | $67,101.67MM | $76,590.11MM |
| Operating Cash Flow | $3,911.33MM | $3,484.68MM | $3,875.12MM |
| Capital expenditure | $458.36MM | $487.17MM | $667.98MM |
| Investing Cash Flow | $-2,602.47MM | $-618.10MM | $-4,977.29MM |
| Financing Cash Flow | $-2,222.28MM | $-2,330.99MM | $2,249.11MM |
| Earnings Per Share** | $8.62 | $7.60 | $8.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.